The unmet need in non-alcoholic steatohepatitis (NASH) is getting bigger and bigger. In the decade up to 2032, the number of diagnosed cases in seven major markets is forecast to grow by 4.5 million, ...
According to SNS Insider, the global Non-Alcoholic Steatohepatitis Treatment Market was valued at $7.70 billion in 2024 and is projected to reach $55.52 billion by 2032 with a CAGR of 28.05% from 2025 ...
Dublin, Feb. 07, 2020 (GLOBE NEWSWIRE) -- The "NASH Drug Pipeline and Market Overview" report has been added to ResearchAndMarkets.com's offering. No medications have been approved specifically for ...
The approval of the first dedicated NASH treatment, Resmetirom (Rezdiffra) in 2024, marked a historic turning point for the industry. As the first therapy targeting MASH with histological improvement ...
The global therapeutic market catering to the widely prevalent liver disease non-alcoholic steatohepatitis (NASH) is projected to reach $48.3B by 2035, international consulting firm Research Nester ...
(Reuters) - Large drugmakers with piles of cash are on the hunt for promising medicines being developed by small companies to treat NASH, a progressive fatty liver disease poised to become the leading ...
Modern Engineering Marvels on MSN
Can Nash bargaining solve space debris economics?
Orbiting at speeds of about 7.5 kilometers a second, even a piece of debris smaller than a centimeter across can severely ...
DUBLIN, May 6, 2021 /PRNewswire/ -- The "Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. According to this report, ...
The NASH treatment market will have significant dependence on two underappreciated indirect factors that are largely undetermined at this point. The size of the addressable NASH market will depend on ...
DUBLIN--(BUSINESS WIRE)--The "Global Non-Alcoholic Steatohepatitis (NASH) Drugs Market: Industry Analysis & Outlook (2017-2026)" report has been added to Research and Markets' offering. The report ...
A recent survey found that doctors are most excited about semaglutide in treating NASH. Treating the liver disease could be a massive market over the next few years. It's way too early to predict that ...
Morning Overview on MSN
Can Nash bargaining fix the economics of space debris?
Low Earth orbit is starting to look less like pristine frontier and more like a crowded shipping lane, with fragments of old ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback